NFE2L2 and chronic kidney disease: The answer to the second question of whether the Nrf2 response to curcumin is coupled with a desirable effect on CKD progression or a reduction in CKD-attributable morbidity is unclear, partially due to the very low number of included CKD patients, and partially because the observed salutary effects were not paralleled by respective Nrf2-system changes.